Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rodolfo Álvarez-Sala
Observed name:
R. Álvarez-Sala
Institutions:
Hospital Universitario La Paz,
Hospital La Paz Institute for Health Research,
Universidad Autónoma de Madrid
Observed institutions:
Hospital Universitario La Paz,
Hospital La Paz Institute for Health Research,
Centro de Investigación Biomédica en Red,
Universidad Autónoma de Madrid
ORCID:
0000-0001-5368-7537
Observed ORCID:
0000-0001-5368-7537
OpenAlex ID:
A5082889176
Efficacy Assessment of Biological Treatments in Severe Asthma
2025
·
Daniel Laorden
, Javier Domínguez-Ortega
, et al.
·
Journal of Clinical Medicine
·
22
PDF
A real life cohort of mepolizumab treatment in severe eosinophilic asthma
2023
·
D. Laorden
, I. Hernández
, et al.
·
European Annals of Allergy and Clinical Immunology
·
9
PDF
Adherence to Intranasal Corticosteroids in Patients with Severe Asthma and Nasal Polyposis: Pharmacological and Clinical Factors Involved
2025
·
Elena Villamañán
, Daniel Laorden
, et al.
·
Journal of Clinical Medicine
·
4
PDF
Inhaled Corticosteroid Reduction Effects on Asthma Outcomes After Three Years of Benralizumab Treatment in Severe Asthma Patients
2025
·
Marta Arteaga
, Laura López-Duque
, et al.
·
Archivos de Bronconeumología
·
3
Fisiopatología de la ventilación y del intercambio gaseoso
2026
·
M. Arteaga
, E. De Dios
, et al.
·
Medicine - Programa de Formación Médica Continuada Acreditado
Inhalers and climate change: A sustainable approach to severe asthma management
2026
·
Elena Villamañán
, Daniel Laorden
, et al.
·
Respiratory Medicine
Inhaled Corticosteroid Reduction Effects on Asthma Outcomes after Three Years of Benralizumab Treatment in Severe Asthma Patients
2025
·
Marta Arteaga Romero
, Laura López-Duque
, et al.
·
European Respiratory Journal
Paciente fumador con múltiples ingresos por broncoespasmo
2013
·
D. Romero
, P. Barranco
, et al.
·
ESPACIO ASMA
Show more works
View as search
Works count:
8
Citation count:
38
H-index:
3
I10-index:
1
Year
Topic
Type